In addition to the anti-cancer properties, the efficient immune activation and reversal of ITM by UA was evaluated, and it was suggested to be an available combination strategy to assist the ICB gene therapy of PD-L1 (Scheme 1B). This evidence concerns the gene CD274 and cancer.